XML 20 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Unaudited Condensed Consolidated Statement of Cash Flows Statement - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities:    
Net income $ 185,329 $ 243,311
Adjustments to reconcile net income to net cash provided by operating activities:    
Loss on early extinguishment of debt, net (10,131) 0
Depreciation and amortization 78,069 75,455
Amortization of intangibles 13,645 14,051
Amortization of cemetery property 29,813 30,596
Amortization of loan costs 3,017 2,881
Provision for doubtful accounts 4,494 4,544
Provision for (benefit from) deferred income taxes 22,011 (153,112)
Gains on divestitures and impairment charges, net (7,347) (5,688)
Gain on sale of investments (2,636) 0
Share-based compensation 7,544 7,645
Change in assets and liabilities, net of effects from acquisitions and divestitures:    
Decrease in receivables 965 20,441
Increase in other assets (10,635) (7,815)
(Decrease) increase in payables and other liabilities (37,817) 14,815
Effect of preneed production and maturities:    
Increase in preneed receivables, net and trust investments (23,494) (64,860)
Increase in deferred revenue, net 56,342 36,345
(Decrease) increase in deferred receipts held in trust (14,055) 3,880
Net cash provided by operating activities 315,376 222,489
Cash flows from investing activities:    
Capital expenditures (102,890) (85,324)
Acquisitions, net of cash acquired (167,622) (46,373)
Proceeds from divestitures and sales of property and equipment 18,305 25,329
Proceeds from Sale, Maturity and Collection of Investments 2,900  
Payments for Company-owned life insurance policies (11,733) (3,180)
Proceeds from Company-owned life insurance policies 2,810 2,591
Payments for (Proceeds from) Other Investing Activities 14,525 (175)
Net cash used in investing activities (272,755) (106,782)
Cash flows from financing activities:    
Proceeds from issuance of long-term debt 370,000 110,000
Scheduled payments of debt (8,631) (17,570)
Early payments of debt (259,590) 0
Principal payments on capital leases 19,270 30,419
Proceeds from exercise of stock options 7,302 20,601
Purchase of Company common stock (228,866) (120,064)
Payments of dividends (62,241) (52,529)
Payments to Acquire Additional Interest in Subsidiaries 0 4,580
Bank overdrafts and other (8,820) (2,065)
Net cash used in financing activities (210,116) (96,626)
Effect of foreign currency on cash, cash equivalents, and restricted cash (2,133) 4,072
Net (decrease) increase in cash, cash equivalents, and restricted cash (169,628) 23,153
Cash, cash equivalents, and restricted cash at beginning of period 340,601 $ 211,506
Cash, cash equivalents, and restricted cash at end of period $ 170,973